Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
about
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesMapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice.Genetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains.Influence of phthalates on glucose homeostasis and atherosclerosis in hyperlipidemic micePET imaging detection of macrophages with a formyl peptide receptor antagonistIn vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid deliveryNew quantitative trait loci for carotid atherosclerosis identified in an intercross derived from apolipoprotein E-deficient mouse strains.Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.Characterization of Bglu3, a mouse fasting glucose locus, and identification of Apcs as an underlying candidate gene.The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery diseaseMetabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking.An accelerated mouse model for atherosclerosis and adipose tissue inflammation.Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells.Accelerated atherogenesis in completely ligated common carotid artery of apolipoprotein E-deficient mice.
P2860
Q26822630-E0145817-14BE-4960-ADCD-ACA9244EE724Q30277373-20059C45-3852-454C-8888-8A91FE9AD004Q30278356-A090F006-DEFE-412A-9FB6-5CE8DC20FB94Q30300182-9F08B3F0-388B-4B0A-A223-44DD0DFA37EEQ30301085-FED0F730-43C2-4B7C-A97D-D6B28CFCD1E2Q30410751-18CDB6CC-C4D1-4057-80A9-4111753A74C0Q30413841-F6BDFCC9-7BC9-4C20-9569-611D4D6263ECQ30421525-F55B3F14-E011-4BE6-91FA-AADEE46F65E1Q30421914-F84A2992-8B6C-43B0-962D-71E5AD997968Q33562214-52C95142-954D-4FBD-8AF2-62B6E6B8F2FFQ36023835-C86A3247-718F-409B-906F-F7E91592D8ADQ36767410-24A139B0-CF9F-4CD2-884F-952BD9C991C1Q37515725-B643880B-9E4A-4109-A8C2-CB4612C0EECAQ39269910-BBE40F12-6BC5-4FF5-9542-AC5CBA720ACAQ41266076-5D5B0FD0-5391-494B-B5B8-D17ABEBD8A28Q49334737-C48CA4B8-93B7-422B-ABE3-1B6068609EE1
P2860
Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@ast
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@en
type
label
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@ast
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@en
prefLabel
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@ast
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@en
P2093
P2860
P356
P1476
Hyperglycemia in apolipoprotei ...... therosclerosis susceptibility.
@en
P2093
Mei-Hua Chen
Weidong Chai
Zhenqi Liu
P2860
P2888
P356
10.1186/1475-2840-10-117
P407
P50
P577
2011-12-28T00:00:00Z
P5875
P6179
1012954040